Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

ANGO

AngioDynamics (ANGO)

AngioDynamics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANGO
DateTimeSourceHeadlineSymbolCompany
23/10/202423:00Business WireAngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® SystemNASDAQ:ANGOAngioDynamics Inc
21/10/202423:00Business WireAngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and LiverNASDAQ:ANGOAngioDynamics Inc
11/10/202406:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
09/10/202409:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
09/10/202407:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
04/10/202407:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANGOAngioDynamics Inc
03/10/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANGOAngioDynamics Inc
03/10/202420:30Business WireAngioDynamics Reports Fiscal Year 2025 First Quarter Financial ResultsNASDAQ:ANGOAngioDynamics Inc
27/09/202404:59Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ANGOAngioDynamics Inc
27/09/202404:57Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ANGOAngioDynamics Inc
20/09/202406:40Business WireAngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional OutcomesNASDAQ:ANGOAngioDynamics Inc
19/09/202422:00Business WireAngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024NASDAQ:ANGOAngioDynamics Inc
03/09/202422:30Business WireAngioDynamics Announces CE Mark Approval in Europe for the Auryon SystemNASDAQ:ANGOAngioDynamics Inc
03/08/202411:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
03/08/202411:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
03/08/202411:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
03/08/202411:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
03/08/202411:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
03/08/202411:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
03/08/202411:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
03/08/202411:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
03/08/202411:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
03/08/202411:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
30/07/202406:15Business WireAngioDynamics to Participate in Upcoming Investor ConferencesNASDAQ:ANGOAngioDynamics Inc
26/07/202411:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
26/07/202411:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
26/07/202411:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
26/07/202411:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
26/07/202411:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANGOAngioDynamics Inc
26/07/202406:13Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ANGOAngioDynamics Inc
 Showing the most relevant articles for your search:NASDAQ:ANGO